Aktiespot

Eris Lifesciences Limited Aktie

ERIS.BO

Geschlossen
₹1,361.05-6.50 (-0.48%)
Chart wird geladen...

Eris Lifesciences Limited

Eröffnung1,373.65
Hoch1,379.60
Tief1,352.45
Volumen5.74k
P/E30.07
Marktkapitalisierung188.6B
52-Wochen-Hoch1,909.55
52-Wochen-Tief1,237.90
Durchschn. Volumen21.05k
Dividende1.05%
Beta-0.11
EPS45.27

Über Eris Lifesciences Limited Aktie

Eris Lifesciences Limited, together with its subsidiaries, provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally. The company offers various branded formulations in various therapeutic areas, such as anti–diabetes, cardiovascular, nutrition, dermatology, neuroscience, gynecology, nephrology, and oncology, as well as central nervous system, women's health, and vitamins/minerals/nutrients. It also provides patient care services, including ambulatory blood pressure measurement, ambulatory electrocardiogram measurement, continuous glucose monitoring system, sleep study, and anti-natal care solutions. It offers its products through wholesale drug distributors, stockists, retail and e-commerce pharmacies. Eris Lifesciences Limited was incorporated in 2007 and is headquartered in Ahmedabad, India.

Unternehmensinformationen

Börse: BSE (BSE)
Sektor: Sundhed
Branche: Lægemiddelproducenter – Special og generisk
Adresse:
Shivarth Ambit
380054 Ahmedabad, India
Telefon: + 91 79 6966 1000

Analystenempfehlungen

Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.

Anbefaling:1.30 - Stærk køb
Niedrigstes Kursziel
1,435.00
5.4%
Durchschnittliches Kursziel
1,696.60
24.7%
Median Kursziel
1,720.50
26.4%
Höchstes Kursziel
1,940.00
42.5%

Andere sehen auch: